Literature DB >> 10747885

Stimulation of DNA synthesis and cell proliferation of human mammary myoepithelial-like cells by hepatocyte growth factor/scatter factor depends on heparan sulfate proteoglycans and sustained phosphorylation of mitogen-activated protein kinases p42/44.

N Sergeant1, M Lyon, P S Rudland, D G Fernig, M Delehedde.   

Abstract

Hepatocyte growth factor/scatter factor (HGF/SF) is a heparan/dermatan sulfate-binding growth factor produced by stromal cells that acts as a paracrine effector on neighboring epithelia. HGF/SF stimulated DNA synthesis in human mammary (Huma) 109 myoepithelial-like cells grown on collagen I and fibronectin substrata but not when grown on plastic. Dual phosphorylation of mitogen-activated protein kinases (p42/44(MAPK)) was required for this stimulation of DNA synthesis. In Huma 109 cells cultured on plastic, HGF/SF stimulated a transient phosphorylation of p42/44(MAPK), which reached a maximum at 10 min after addition of the growth factor and returned to near basal levels after 20 min. In contrast, the phosphorylation of p42/44(MAPK) stimulated by HGF/SF in cells cultured on collagen I or fibronectin was sustained over 45 min. In Huma 109 cells deficient in sulfated glycosaminoglycans, HGF/SF failed to stimulate p42/44(MAPK) phosphorylation or DNA synthesis on any substratum, even when soluble heparan sulfate proteoglycans purified from the cells or from the culture medium were added. However, HGF/SF stimulated DNA synthesis and a sustained phosphorylation of p42/44(MAPK) in sulfated glycosaminoglycan-deficient Huma 109 cells plated on a substratum of medium HSPGs but not cell HSPGs. The HGF/SF-induced proliferation is thus highly dependent on heparan sulfate proteoglycans in myoepithelial-like cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747885     DOI: 10.1074/jbc.M000237200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  PKC controls HGF-dependent c-Met traffic, signalling and cell migration.

Authors:  Stéphanie Kermorgant; Daniel Zicha; Peter J Parker
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

2.  A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen.

Authors:  Boryana M Eastman; Minji Jo; Drue L Webb; Shinako Takimoto; Steven L Gonias
Journal:  Cell Signal       Date:  2012-05-19       Impact factor: 4.315

Review 3.  Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland.

Authors:  M Delehedde; M Lyon; N Sergeant; H Rahmoune; D G Fernig
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

4.  Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix.

Authors:  Fabrice Allain; Christophe Vanpouille; Mathieu Carpentier; Marie-Christine Slomianny; Sandrine Durieux; Geneviève Spik
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

5.  Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.

Authors:  D J Webb; K S Thomas; S L Gonias
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

6.  Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition.

Authors:  B L Allen; M S Filla; A C Rapraeger
Journal:  J Cell Biol       Date:  2001-11-26       Impact factor: 10.539

Review 7.  Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis.

Authors:  J W Pollard
Journal:  Breast Cancer Res       Date:  2001-06-14       Impact factor: 6.466

8.  Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase.

Authors:  Nirmita J Patel; Chetna Sharon; Somesh Baranwal; Rio S Boothello; Umesh R Desai; Bhaumik B Patel
Journal:  Oncotarget       Date:  2016-12-20

9.  Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses.

Authors:  Valeria De Pasquale; Patrizia Sarogni; Valeria Pistorio; Giuliana Cerulo; Simona Paladino; Luigi Michele Pavone
Journal:  Mol Ther Methods Clin Dev       Date:  2018-06-18       Impact factor: 6.698

10.  Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.

Authors:  Maryse Delehedde; Lucie Devenyns; Claude-Alain Maurage; Romain R Vivès
Journal:  Int J Cell Biol       Date:  2013-03-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.